Sandeep Menon
CIK: 0002123967
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BCRX
BIOCRYST PHARMACEUTICALS INC
Officer
Discretionary Trading P&L
Holdings
About Menon Sandeep
Menon Sandeep (SEC CIK 0002123967) files insider reports with the SEC as Chief R&D Officer of BIOCRYST PHARMACEUTICALS INC (BCRX).
Signal8 holds 2 ownership filings by Menon Sandeep (1 Form 3, 1 Form 4), filed on Apr 7, 2026. Those filings report 1 transaction, the latest on Apr 6, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Menon Sandeep's filings is in DURHAM, NC.
Recent filings by Menon Sandeep
- Apr 6, 2026: Grant or award of BCRX shares (Form 4, code A).
Other insiders filing for BIOCRYST PHARMACEUTICALS INC (BCRX)
- Stonehouse Jon P, Director
- Milne Jill C., Director
- MILANO VINCENT, Director
- McKee Amy E, Director
- Frank Steven, Director
- Galson Steven K, Director